In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.
Provided by Social Market Analytics, here is the social media outlook for Friday, July 13.
Most Bullish
MBIA MBI released its exposure to San Bernardino, California as it files for bankruptcy. The stock fell in early trading, even as call option buying was well above normal volume.
Quest Diagnostics DGX more than 5 percent Thursday on news that Merck MRK is suspending its trial on a new osteoporosis drug, after results exceeded expectations. Quest is entitled to royalty payments on this drug worth at least $2 per share, according to Lazard analyst Tom Galluci
Most Bearish
Map Pharmaceuticals MAPP rose on elevated option activity.
Infosys Ltd. INFY rose in early New York trading, even as analysts HSBC reiterated a Neutral rating on the stock and cut its price target.
Most Discussed
JP Morgan Chase JPM reported first quarter earnings that were in line with expectations after items relating to the CIO trading loss are backed out. The bank also gave an update on the trading loss.
Apple AAPL is frequently discussed on social media. Reports show that sales in Iran are booming even with ongoing sanctions.
Complete Genomics GNOM Complete Genomics rose nearly 44 percent Thursday after the company announced that it has discovered a new method of sequencing genomes that requires less material and improves accuracy ten-fold.
Supervalu Inc. SVU fell after it pre-announced a large miss of earnings and suspended its dividend. Subsequently, S&P put its B+ credit rating on review with a negative outlook.
Wells Fargo WFC reported earnings Friday morning, beating expectations. The stock rose in early New York trading.
Interested in getting more information about stock trends on social media? Signup for the Social Market Analytics newsletter on their website.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.